Hyperbaric Oxygen in Lower Leg Trauma
Tibial Fracture, Soft Tissue Injury
About this trial
This is an interventional treatment trial for Tibial Fracture focused on measuring Hyperbaric oxygen, Crush injury, Tibial fracture, Gustillo 3, soft tissue injury, complications, outcomes, randomised controlled trial
Eligibility Criteria
Inclusion Criteria: Acute fracture of the tibia with significant soft tissue injury of Gustilo Grade 3 Enrolment within 48 hours of injury with expectation of commencement of HBO therapy within 48 hours of injury Valid consent Exclusion Criteria: Significant head injury Injuries incompatible with HBO resuscitation requirements incompatible with HBO follow up not possible hyperbaric contra indications
Sites / Locations
- John Muir Clinical Research Center
- Royal Hobart Hospital
- The Alfred
- Universitatsklinikum Graz
- Hospital del Trabajador
- City Hospital of Ostrava
- Indraprastha Apollo Hospital
- Policlinico Umberto 1, University of Rome
- Hospital Pedro Hispano
- Karolinska Hospital
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Hyperbaric oxygen treatment
No hyperbaric oxygenation
Subjects in the HBO treatment group will receive a course of hyperbaric oxygen therapy (HBO) in addition to normal trauma and general care. A total of 12 HBO sessions will be delivered over approximately 8 days. HBO treatment will be provided at 2.4 atmospheres absolute (ATA) pressure for approximately 90 minutes of oxygen therapy. Treatments should be twice daily for the first three days. Minor variability will be allowed with respect to timing and profile of each session.
Patients randomised to this group will receive standard trauma care.